Peripheral Blood Profiling to Screen Patients for Lung Cancer or Lung Cancer Recurrence

What is the purpose of this trial?

The purpose of this study is to screen patients at risk for lung cancer, or lung cancer recurrence using a novel sequencing technique to detect fragments of mutated DNA in the peripheral blood.



Yale University School of Medicine

Dates: 09/03/2014 - 09/30/2024

Last Updated: 09/06/2017

Study HIC#: 1407014379

Get Involved

For more information about this study, contact:
Cynthia Bensley
203-737-2015
cynthia.bensley@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Daniel J. Boffa

Principal Investigator

Sub-Investigators